Hao Hu, PhD, is the Sr. Director of HEOR for Global Value and Access Oncology at Gilead Sciences. They previously worked as a Department Head in Biometrics at Servier and managed biostatistics at IQVIA. Hao has also held roles at Novo Nordisk and China National HTA Center, contributing expertise in biostatistics, bioinformatics, and health economics. They earned a PhD in HEOR from the University of Newcastle and hold two master's degrees from Katholieke Universiteit Leuven in Statistics and Bioinformatics.
This person is not in any teams
This person is not in any offices